Adynxx, Inc. (ADYX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 27, 2026, 9:30 AM EST
Adynxx Market Cap
Adynxx has a market cap or net worth of $581 as of April 28, 2026. Its market cap has decreased by -99.98% in one year.
Market Cap
581.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 6, 2019, Adynxx's market cap has decreased from 52.42M to 581.00, a decrease of -100.00%. That is a compound annual growth rate of -80.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 581.00 | - |
| Dec 10, 2025 | 581.00 | 9,583.33% |
| Dec 30, 2024 | 6.00 | -99.48% |
| Dec 31, 2021 | 1.16K | -99.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| eFFECTOR Therapeutics | 941.00 |
| RegeneRx Biopharmaceuticals | 754.00 |
| Alzex Neuropharma | 753.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| GlobeImmune | 575.00 |